echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > New Zhihui forum | Bai Yu: drugstores need to improve non drug handling capacity under the reform of medical insurance and fee control

    New Zhihui forum | Bai Yu: drugstores need to improve non drug handling capacity under the reform of medical insurance and fee control

    • Last Update: 2020-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    JavaScript is required to play the video, and the browser is recommended Nowadays, under the policies of 4 + 7 and DRG, the pharmaceutical ecological environment is undergoing dramatic changes, and the industry as a whole is facing transformation and upgrading Which areas will be the golden track in the future? How to adjust the production capacity and marketing strategy in the reshuffle of production, circulation and retail enterprises? On December 28, 2019, under the guidance of China Pharmaceutical Materials Association and jointly sponsored by Sina pharmaceutical and China Pharmaceutical Materials Association think tank for food and drug industry, the "2019 China Pharmaceutical new wisdom forum" and "new wisdom 2019 pharmaceutical industry annual value pioneer list award ceremony" were held in Beijing In the interview room of sina pharmaceutical, I would like to talk with us about the direction of industrial transformation under the transformation and upgrading of pharmaceutical industry, as well as the development prospect of production and distribution enterprises and other hot topics The field of medical devices will be a golden track We are about to enter the era of half human and half machine Most of our functions and organs in the future will be gradually replaced by machines, such as some artificial pancreas, intelligent wearable equipment, intelligent artificial limbs, etc There is also the digital opportunity for medical devices, especially the intelligent hardware of medical devices, from a bubble period to a landing popularity period There are opportunities in the fields of comprehensive digitalization and real-time online monitoring There are also opportunities to get rid of the IQ tax For example, the price of health care products was falsely high before Pyramid selling, marketing and experience marketing became the main models in this field, but now these are all being subverted Both the government's supervision and the people's awareness are upgrading This is an era of getting rid of the IQ tax for health care products and big health products As well as helping chain drugstores to integrate and improve their professional management ability, such as managing non drugs such as devices, which is still very valuable for drugstores Another insurance with patients is also a competition With intelligent digitalization, there will be a blue ocean in this field in the future In fact, the whole "4 + 7" volume purchasing and DRG payment methods are changing dramatically, which mainly affects the industry and circulation With the deepening of 4 + 7 volume purchase, many product prices have been squeezed out, including single disease payment, which breaks the previous situation of not making money on drugs, but making money on medical devices or other aspects Under such circumstances, enterprises should solve their own production efficiency problems as soon as possible The country hopes that the pharmaceutical production industry will become a pure chemical pharmaceutical industry enterprise, rather than a marketing industry The era of marketing has gone forever At least in the field of prescription drugs, the change of marketing mode has brought opportunities to innovative pharmaceutical enterprises Today, we see that Hengrui's market value is very high In fact, it is the capital market that votes with its feet to tell you that only such innovative enterprises can have a future In this way, you can either become an innovative company or an efficiency company, control the cost of API and improve the production efficiency Under the influence of the policy, the pharmaceutical circulation industry has actually entered a new era Last year, I hosted about 20 dialogues and forums in the pharmaceutical industry The mainstream view of the pharmaceutical retail industry is that in the next decade, the number of retail pharmacies in China will change from 489000 to about 300000, that is to say, nearly 40% of them will be closed, leaving only professional pharmacies, which means that Millions of people are out of work The main reason for the reshuffle is that the structure of the whole product of the drugstore is changing For example, before you lived on prescription drugs, after 4 + 7 volume purchase, the profit decreased, and it is difficult for the drugstore to support only by this profit This forces chain drugstores to do a good job in the management of non drugs, including medical devices, including health care, food, nutrition and other fields The second is the operation ability of non-medical insurance It is strictly prohibited to swipe the medical insurance card randomly now The operation ability of non-medical insurance determines the survival ability of drugstores in the future In the future, convenience stores, automatic medicine selling machines and online pharmacies will become new and important channels, and the sales growth of these channels will be much faster than that of offline pharmacies Under the new increment, the manufacturers, especially the operators of brand drugs, should pay more attention to where the new increment is than before, because the new increment means that you may not need to invest too much, and you can have good profits But the stock part is also a process of saving quantity and increasing increment Among them, the construction of new channels is very important, especially now the policy of medicine e-commerce is gradually implemented, and the legislation of online drug sales begins, which is an obvious trend The operation efficiency of medical e-commerce is high, the exposure rate and brand exposure rate are better than offline drugstores, and then traceability Production enterprises should be close to customers and new channels as soon as possible For production enterprises, where customers are, sales channels should aim at where The state issued a request to share prescription information across the country At present, with the release of online prescription drugs, prescription information sharing is no longer a bottleneck And the drugs sold on the Internet are mostly chronic drugs The first complaint of patients with chronic diseases is long-term and the rate of re purchase is high Therefore, the slow disease management and online health management are more likely to interact with patients In addition, more services based on a single disease will be extended, such as the insurance for people with disease, the relationship between drugs and devices, and the relationship between drugs and nutrition In the future, we will gradually establish this strong relationship with customers in the whole chronic disease management, and finally realize the long-term digital based, drug-based electronic drug records and electronic medical records of this kind of medication reminders and Long term health care, I think it will be a very good development trend China certainly doesn't need so many pharmaceutical factories Everyone should have a clear understanding Many enterprises may focus on their core capabilities, or improve production efficiency, or conduct new drug research and development, or do a good job in service In addition, non drug treatment methods such as medical devices, nutrition, and single disease based solutions companies will become more and more popular in the future There is also a good opportunity for Internet hospitals to integrate resources and better serve patients In the future, it will take at least 100 years or more to rebuild a Concorde hospital or Xiangya Hospital offline, but we have the opportunity to establish an online and offline interactive hospital similar to Concorde hospital in a single disease field New solutions, new business models and new business formats will all happen here In addition, in the process of digitalization, many companies based on Digitalized health management have emerged in our Congress These companies will be very valuable, such as focusing on diabetes, chronic kidney disease, cardiovascular and cerebrovascular fields, which can integrate medicine, nutrition and insurance.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.